SH
SHSCX
ETF
SHSCX
·
UNKNOWN
·
141 holdings
About SHSCX
No description available for this ETF.
Fund Details
- Expense Ratio
- —
- Inception Date
- —
- Prev. Close
- € 47,49
- Exchange
- UNKNOWN
- Currency
- USD
- Holdings As Of
- Apr 10, 2026
- Tracked Holdings
- 84.4%
- HHI Score
- 352,87
- Top Sector
- Healthcare (95.500842%)
Positive 1W (+0.77%) after negative 1M (-2.4%) — trend may be reversing
47,98%
Moderately Concentrated
Diversified
Concentrated
The top 10 holdings represent 47,98% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.
Weighted by position size
Weighted avg. of top holdings
▼ -1,46%
TMO
Thermo Fisher Scientific Inc
UNH
UnitedHealth Group Inc
ISRG
Intuitive Surgical Inc
All Holdings (141)
Top 10: 47,98% of fund
| # |
Ticker |
Name |
Weight |
Shares |
Market Value |
| 1 |
LLY
|
Eli Lilly & Co |
10,89% |
687.214 |
739,08 M |
| 2 |
JNJ
|
Johnson & Johnson |
8,37% |
2,75 M |
568,32 M |
| 3 |
ABT
|
Abbott Laboratories |
5,03% |
2,65 M |
341,31 M |
| 4 |
ABBV
|
AbbVie Inc |
3,97% |
1,18 M |
269,32 M |
| 5 |
TMO
|
Thermo Fisher Scientific Inc |
3,69% |
424.384 |
250,74 M |
| 6 |
UNH
|
UnitedHealth Group Inc |
3,57% |
736.018 |
242,72 M |
| 7 |
AMGN
|
Amgen Inc |
3,41% |
670.330 |
231,57 M |
| 8 |
MDT
|
Medtronic PLC |
3,37% |
2,17 M |
228,50 M |
| 9 |
GILD
|
Gilead Sciences Inc |
2,94% |
1,59 M |
199,49 M |
| 10 |
ISRG
|
Intuitive Surgical Inc |
2,75% |
325.960 |
186,93 M |
| 11 |
BSX
|
Boston Scientific Corp |
2,75% |
1,84 M |
186,55 M |
| 12 |
DHR
|
Danaher Corp |
2,25% |
674.518 |
152,97 M |
| 13 |
SYK
|
Stryker Corp |
2,24% |
410.154 |
152,24 M |
| 14 |
EW
|
Edwards Lifesciences Corp |
2,23% |
1,75 M |
151,50 M |
| 15 |
MRK
|
Merck & Co Inc |
2,06% |
1,34 M |
140,00 M |
| 16 |
ALNY
|
Alnylam Pharmaceuticals Inc |
1,96% |
295.219 |
133,21 M |
| 17 |
MCK
|
McKesson Corp |
1,72% |
132.195 |
116,48 M |
| 18 |
COR
|
Cencora Inc |
1,62% |
298.082 |
109,97 M |
| 19 |
AZN
|
AstraZeneca PLC |
1,25% |
459.512 |
85,20 M |
| 20 |
ROG
|
Roche Holding AG |
1,21% |
214.550 |
82,19 M |
| 21 |
REGN
|
Regeneron Pharmaceuticals Inc |
1,15% |
99.733 |
77,81 M |
| 22 |
TEVA
|
Teva Pharmaceutical Industries |
1,08% |
2,73 M |
73,49 M |
| 23 |
BMY
|
Bristol-Myers Squibb Co |
1,01% |
1,40 M |
68,84 M |
| 24 |
INSM
|
Insmed Inc |
1,00% |
326.291 |
67,79 M |
| 25 |
ARGX
|
Argenx SE |
0,97% |
72.459 |
66,08 M |
| 26 |
HCA
|
HCA Healthcare Inc |
0,96% |
128.427 |
65,28 M |
| 27 |
A
|
Agilent Technologies Inc |
0,92% |
406.802 |
62,44 M |
| 28 |
VRTX
|
Vertex Pharmaceuticals Inc |
0,91% |
143.095 |
62,05 M |
| 29 |
BIIB
|
Biogen Inc |
0,89% |
330.978 |
60,27 M |
| 30 |
RYTM
|
Rhythm Pharmaceuticals Inc |
0,88% |
550.460 |
60,05 M |
| 31 |
IDXX
|
IDEXX Laboratories Inc |
0,85% |
76.237 |
57,40 M |
| 32 |
EXAS
|
Exact Sciences Corp |
0,84% |
559.938 |
56,72 M |
| 33 |
IQV
|
IQVIA Holdings Inc |
0,76% |
224.389 |
51,61 M |
| 34 |
WAT
|
Waters Corp |
0,67% |
112.688 |
45,46 M |
| 35 |
DXCM
|
Dexcom Inc |
0,63% |
678.143 |
43,04 M |
| 36 |
INCY
|
Incyte Corp |
0,62% |
404.753 |
42,28 M |
| 37 |
PEN
|
Penumbra Inc |
0,59% |
136.101 |
39,90 M |
| 38 |
LH
|
Labcorp Holdings Inc |
0,56% |
141.526 |
38,04 M |
| 39 |
GH
|
Guardant Health Inc |
0,55% |
343.956 |
37,29 M |
| 40 |
NUVL
|
Nuvalent Inc |
0,52% |
322.681 |
35,29 M |
| 41 |
PTGX
|
Protagonist Therapeutics Inc |
0,50% |
378.430 |
34,06 M |
| 42 |
WST
|
West Pharmaceutical Services I |
0,47% |
116.000 |
32,16 M |
| 43 |
NTRA
|
Natera Inc |
0,47% |
133.100 |
31,79 M |
| 44 |
GALD
|
Galderma Group AG |
0,46% |
156.652 |
31,27 M |
| 45 |
PFE
|
Pfizer Inc |
0,46% |
1,21 M |
31,15 M |
| 46 |
ELV
|
Elevance Health Inc |
0,45% |
90.524 |
30,62 M |
| 47 |
PODD
|
Insulet Corp |
0,44% |
91.564 |
29,96 M |
| 48 |
CVS
|
CVS Health Corp |
0,43% |
367.062 |
29,50 M |
| 49 |
UCB
|
UCB SA |
0,38% |
92.407 |
25,83 M |
| 50 |
VEEV
|
Veeva Systems Inc |
0,36% |
101.554 |
24,40 M |
| 51 |
THC
|
Tenet Healthcare Corp |
0,36% |
111.596 |
24,20 M |
| 52 |
RGEN
|
Repligen Corp |
0,35% |
139.542 |
23,86 M |
| 53 |
BRKR
|
Bruker Corp |
0,35% |
482.169 |
23,53 M |
| 54 |
COO
|
Cooper Cos Inc/The |
0,34% |
299.483 |
23,34 M |
| 55 |
CNC
|
Centene Corp |
0,32% |
557.433 |
21,93 M |
| 56 |
DGX
|
Quest Diagnostics Inc |
0,32% |
113.440 |
21,46 M |
| 57 |
UTHR
|
United Therapeutics Corp |
0,30% |
41.636 |
20,24 M |
| 58 |
MRUS
|
Merus NV |
0,29% |
206.777 |
19,88 M |
| 59 |
HUM
|
Humana Inc |
0,29% |
80.397 |
19,76 M |
| 60 |
ILMN
|
Illumina Inc |
0,29% |
149.093 |
19,60 M |
| 61 |
GEHC
|
GE HealthCare Technologies Inc |
0,27% |
231.768 |
18,54 M |
| 62 |
BMRN
|
BioMarin Pharmaceutical Inc |
0,27% |
329.622 |
18,44 M |
| 63 |
STE
|
STERIS PLC |
0,26% |
66.341 |
17,67 M |
| 64 |
CYTK
|
Cytokinetics Inc |
0,25% |
251.375 |
17,13 M |
| 65 |
4568
|
Daiichi Sankyo Co Ltd |
0,25% |
688.300 |
16,96 M |
| 66 |
BBIO
|
Bridgebio Pharma Inc |
0,22% |
209.311 |
15,07 M |
| 67 |
STOK
|
Stoke Therapeutics Inc |
0,22% |
483.398 |
14,94 M |
| 68 |
APGE
|
Apogee Therapeutics Inc |
0,22% |
207.345 |
14,92 M |
| 69 |
MRNA
|
Moderna Inc |
0,22% |
572.943 |
14,89 M |
| 70 |
IONS
|
Ionis Pharmaceuticals Inc |
0,21% |
173.690 |
14,37 M |
| 71 |
ACLX
|
Arcellx Inc |
0,20% |
186.729 |
13,58 M |
| 72 |
TECH
|
Bio-Techne Corp |
0,19% |
198.125 |
12,78 M |
| 73 |
PTCT
|
PTC Therapeutics Inc |
0,18% |
145.525 |
12,51 M |
| 74 |
NBIX
|
Neurocrine Biosciences Inc |
0,18% |
80.426 |
12,24 M |
| 75 |
RCUS
|
Arcus Biosciences Inc |
0,18% |
465.407 |
12,15 M |
| 76 |
MBX
|
MBX Biosciences Inc |
0,17% |
340.569 |
11,75 M |
| 77 |
ELAN
|
Elanco Animal Health Inc |
0,17% |
493.714 |
11,49 M |
| 78 |
HOLX
|
Hologic Inc |
0,16% |
141.365 |
10,60 M |
| 79 |
EXEL
|
Exelixis Inc |
0,15% |
236.668 |
10,45 M |
| 80 |
LBRX
|
LB Pharmaceuticals Inc |
0,15% |
579.919 |
10,32 M |
| 81 |
CRL
|
Charles River Laboratories Int |
0,15% |
57.394 |
10,22 M |
| 82 |
SRRK
|
Scholar Rock Holding Corp |
0,15% |
231.108 |
10,18 M |
| 83 |
ROIV
|
Roivant Sciences Ltd |
0,15% |
478.695 |
9,96 M |
| 84 |
ADARX PHARMACEUTICAL
|
ADARX PHARMACEUTICALS INC |
0,14% |
769.230 |
9,62 M |
| 85 |
GKOS
|
Glaukos Corp |
0,14% |
89.037 |
9,46 M |
| 86 |
LARONDE INC
|
LARONDE INC |
0,14% |
386.520 |
9,39 M |
| 87 |
KARTOS THERAPEUTICS
|
KARTOS THERAPEUTICS INC |
0,13% |
1,57 M |
8,94 M |
| 88 |
BBOT
|
BridgeBio Oncology Therapeutic |
0,12% |
688.356 |
8,47 M |
| 89 |
IRON
|
Disc Medicine Inc |
0,12% |
88.432 |
8,26 M |
| 90 |
BIO
|
Bio-Rad Laboratories Inc |
0,12% |
25.295 |
8,22 M |
| 91 |
NVCR
|
Novocure Ltd |
0,11% |
586.731 |
7,52 M |
| 92 |
OLMA
|
Olema Pharmaceuticals Inc |
0,11% |
259.430 |
7,35 M |
| 93 |
RNA
|
Avidity Biosciences Inc |
0,11% |
101.637 |
7,29 M |
| 94 |
TERN
|
Terns Pharmaceuticals Inc |
0,11% |
256.540 |
7,21 M |
| 95 |
SMMT
|
Summit Therapeutics Inc |
0,10% |
397.896 |
7,12 M |
| 96 |
ENTA
|
Enanta Pharmaceuticals Inc |
0,10% |
502.656 |
7,10 M |
| 97 |
ASND
|
Ascendis Pharma A/S |
0,10% |
32.926 |
6,99 M |
| 98 |
MTD
|
Mettler-Toledo International I |
0,10% |
4.693 |
6,93 M |
| 99 |
EWTX
|
Edgewise Therapeutics Inc |
0,10% |
261.711 |
6,81 M |
| 100 |
DYN
|
Dyne Therapeutics Inc |
0,09% |
284.975 |
6,24 M |
| 101 |
ZEAL
|
Zealand Pharma A/S |
0,09% |
75.695 |
6,08 M |
| 102 |
VTYX
|
Ventyx Biosciences Inc |
0,09% |
603.440 |
6,03 M |
| 103 |
KAILERA THERAPEUTICS
|
KAILERA THERAPEUTICS INC |
0,09% |
428.000 |
5,99 M |
| 104 |
INSITRO INC
|
INSITRO INC |
0,09% |
592.636 |
5,93 M |
| 105 |
ORKA
|
Oruka Therapeutics Inc |
0,08% |
189.022 |
5,69 M |
| 106 |
UPB
|
Upstream Bio Inc |
0,08% |
197.564 |
5,65 M |
| 107 |
QUANTA DIALYSIS TECH
|
QUANTA DIALYSIS TECHNOLOGIES LTD |
0,08% |
80,02 M |
5,51 M |
| 108 |
ALC
|
Alcon AG |
0,08% |
66.973 |
5,31 M |
| 109 |
GENESIS THERAPEUTICS
|
GENESIS THERAPEUTICS INC |
0,07% |
823.870 |
4,56 M |
| 110 |
DNLI
|
Denali Therapeutics Inc |
0,07% |
234.300 |
4,56 M |
| 111 |
PCVX
|
Vaxcyte Inc |
0,07% |
89.436 |
4,44 M |
| 112 |
BNTX
|
BioNTech SE |
0,07% |
42.829 |
4,42 M |
| 113 |
BEAM
|
Beam Therapeutics Inc |
0,06% |
171.649 |
4,35 M |
| 114 |
VKTX
|
Viking Therapeutics Inc |
0,06% |
107.335 |
3,95 M |
| 115 |
KYMR
|
Kymera Therapeutics Inc |
0,06% |
55.346 |
3,76 M |
| 116 |
BHVN
|
Biohaven Ltd |
0,05% |
356.386 |
3,57 M |
| 117 |
LEGN
|
Legend Biotech Corp |
0,05% |
126.380 |
3,50 M |
| 118 |
QURE
|
uniQure NV |
0,05% |
122.925 |
3,38 M |
| 119 |
RGNX
|
REGENXBIO Inc |
0,04% |
219.311 |
2,94 M |
| 120 |
CGON
|
CG oncology Inc |
0,04% |
60.803 |
2,73 M |
| 121 |
BRIDGEBIO ONCOLOGY T
|
BRIDGEBIO ONCOLOGY THERAPEUTICS INC |
0,04% |
209.287 |
2,58 M |
| 122 |
CELLARITY INC
|
CELLARITY INC |
0,03% |
858.333 |
2,03 M |
| 123 |
ALLO
|
Allogene Therapeutics Inc |
0,03% |
1,24 M |
1,80 M |
| 124 |
NYXH
|
Nyxoah SA |
0,02% |
344.664 |
1,65 M |
| 125 |
VYGR
|
Voyager Therapeutics Inc |
0,02% |
379.198 |
1,55 M |
| 126 |
FDMT
|
4D Molecular Therapeutics Inc |
0,02% |
129.009 |
1,50 M |
| 127 |
VIR
|
Vir Biotechnology Inc |
0,02% |
228.276 |
1,47 M |
| 128 |
GOLDFINCH BIO INC
|
GOLDFINCH BIO INC |
0,02% |
3,52 M |
1,41 M |
| 129 |
AFFINIVAX INC
|
AFFINIVAX INC |
0,02% |
122.824 |
1,26 M |
| 130 |
OBIO
|
Orchestra BioMed Holdings Inc |
0,02% |
210.594 |
1,12 M |
| 131 |
AUTL
|
Autolus Therapeutics PLC |
0,02% |
744.753 |
1,05 M |
| 132 |
VOR
|
Vor BioPharma Inc |
0,01% |
117.570 |
979.358,1 |
| 133 |
TCRX
|
TScan Therapeutics Inc |
0,01% |
568.707 |
631.264,77 |
| 134 |
2223637D
|
ABIOMED Inc |
0,01% |
243.643 |
562.815,33 |
| 135 |
MAZE
|
Maze Therapeutics Inc |
0,00% |
6.131 |
231.445,25 |
| 136 |
BPMC
|
BLUEPRINT MEDICINES CORP |
0,00% |
204.909 |
200.810,82 |
| 137 |
MRTX
|
MIRATI THERAPEUTICS INC |
0,00% |
228.510 |
178.237,8 |
| 138 |
CARBON HEALTH TECHNO
|
CARBON HEALTH TECHNOLOGIES INC |
0,00% |
2,72 M |
27.202,77 |
| 139 |
EXO IMAGING INC
|
EXO IMAGING INC |
0,00% |
19.083 |
7.060,71 |
| 140 |
SWIFT HEALTH SYSTEMS
|
SWIFT HEALTH SYSTEMS INC |
0,00% |
1.700 |
3.791,01 |
| 141 |
FREQUENCY THERAPEUTI
|
FREQUENCY THERAPEUTICS CVR |
0,00% |
428.010 |
4,28 |
Showing top 10 of 141 holdings
·
Listed: 99,48%
·
0,52% in other positions
{"event":"ticker_viewed","properties":{"ticker":"SHSCX","listing_kind":"etf","pathname":"/etfs/shscx","exchange":"UNKNOWN"}}